Mr. Neal (for himself and Mr. Brady) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes.
42 U.S.C. 1301, 1320a-7h, 1320b-23, 1395i
and
1395w-3a
Document Citations
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Prescription Drug Sunshine, Transparency, Accountability and Reporting Act. H.R. 2113. 116th
Cong., 1st
sess., Introduced in House April 8, 2019. https://www.govinfo.gov/app/details/BILLS-116hr2113ih.
APA
Congress, House of Representatives (2019, April 8). Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hr2113ih.
MLA
United States, Congress, House of Representatives. Prescription Drug Sunshine, Transparency, Accountability and Reporting Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hr2113ih. 116th Congress, H.R. 2113, Introduced in House 8 Apr. 2019.
Bluebook
H.R.2113 - 116th Congress (2019-2020): Prescription Drug Sunshine, Transparency, Accountability and Reporting Act, H.R.2113, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hr2113ih.
